Nanotechnology: Regulatory outlook on nanomaterials and nanomedicines in United States, Europe and India

R Malik, S Patil - Applied Clinical Research, Clinical Trials and …, 2020 - ingentaconnect.com
Background: The outlook on “Nano-materials, products, medicine and technology'lacks a
consensus on the definition to be considered by regulatory bodies all over the world …

Regulating nanomedicine-can the FDA handle it?

R Bawa - Current drug delivery, 2011 - ingentaconnect.com
There is enormous excitement and expectation surrounding the multidisciplinary field of
nanomedicine-the application of nanotechnology to healthcare-which is already influencing …

A review of the current scientific and regulatory status of nanomedicines and the challenges ahead

SC Hock, YM Ying, CL Wah - PDA Journal of Pharmaceutical …, 2011 - journal.pda.org
Nanomedicines refer to drugs, medical devices, and health products developed using
nanotechnology with the aim of diagnosing, monitoring, and treating diseases at the …

The regulation of nanomaterials and nanomedicines for clinical application: Current and future perspectives

R Foulkes, E Man, J Thind, S Yeung, A Joy… - Biomaterials …, 2020 - pubs.rsc.org
The use of nanomaterials in biomedicine has increased over the past 10 years, with many
different nanoparticle systems being utilised within the clinical setting. With limited emerging …

Toxicity and regulatory concerns for nanoformulations in medicine

N Gaur, N Sharma, A Dahiya, P Yadav… - The ELSI Handbook …, 2020 - Wiley Online Library
With the advancement in science, nanotechnology is gaining importance in every aspect of
life, specifically in medicine. Over the past decade research in nanomedicine has …

Regulatory Considerations for Safety of Nanomaterials

J Kaur, H Singh, M Khatri - Nanomedicine for Bioactives: Healthcare …, 2020 - Springer
Nanoparticles are continuously being used in various industries on a daily basis, exposing
both humans and environment. As previous studies indicate, these nanomaterials tend to …

Nanotechnology and nanomedicine in market: a global perspective on regulatory issues

S Devasahayam - Characterization and biology of nanomaterials for drug …, 2019 - Elsevier
Perceived adverse effects of nanoscience and nanotechnologies (NTs) on health, safety,
and environment (EHS) can impede the progress, competitiveness, and responsible and …

[PDF][PDF] Regulatory roadmap for nanotechnology based medicines

V Limaye, G Fortwengel… - … Journal of Drug …, 2014 - serwiss.bib.hs-hannover.de
Nanotechnology is emerging as one of the key technologies of the 21st century and is
expected to enable developments across a wide range of sectors that can benefit citizens …

Clinical aspects and regulatory requirements for nanomedicines

V Tambe, R Maheshwari, Y Chourasiya… - Basic fundamentals of …, 2019 - Elsevier
The last few decades witnessed the emergence of nanotechnology in the pharmaceutical
sector and the reason for the expansion and evolution of nanomedicines. Nowadays …

Nanotechnology in drug delivery: safety and toxicity issues

K Jain, N Kumar Mehra, NK Jain - Current pharmaceutical …, 2015 - ingentaconnect.com
Nanotoxicology deals with the new perception regarding nanotechnology ie risk and
hazards associated with nanoscale materials. Although, nanotechnology is playing …